They made a lot, a lot of mistakes. Badly designed

They made a lot, a lot of mistakes. Badly designed trials, not raising money when the stock was a lot higher historically, being over promising and under delivering, not managing the CRO and requesting them to file an incomplete BLA, this was all confirmed by Dr JL. “Most inept company”. No need to discuss that. It is a fact. However, this does not affect the molecule. We just need to put it in the hands of a capable company that will get it to humanity. That is all.